In this Research Rundown, we discuss the COVID-19 pandemic (or the “plandemic” as our host calls it), and the effectiveness of Hyperbaric Oxygen Therapy for COVID-19 (SARS-CoV-2).
Highlights:
- We know that early on during the COVID-19 exposure people were dying at an alarming rate. It also became very clear that the ventilators being used were completely ineffective, because there was approximately 90% of people on ventilators who still died from lack of oxygen. Our medical system and the government was clearly using the wrong tool for the job.
- For those familiar with Hyperbaric Oxygen, it was clear that these patients should have been getting HBOT all along. By using the combination of pressure and oxygen, the oxygen is driven into the blood plasma and all vital organs start to again receive the oxygen needed.
- Studies done made it clear that when they separated low-oxygen COVID patients in ICU between two groups — one group on ventilators versus one group getting HBOT, that the vast majority of people who received HBOT survived.
- What’s interesting about this study is that when you get to the end of the study, the conclusion states extremely positive results with the use of HBOT, but then the final sentence states, “It was therefore decided that this study should be terminated”.
- Reason being… the study sort of gets muddy and murky, because now we have vaccines coming into play and we don’t really know what what could be the cause of death and what could be contributing to that.
- Our host, di Girolamo found it disheartening back in the beginning of the pandemic, in 2020, when those within in Hyperbaric Oxygen Therapy field pushed so very hard for the government to allow HBOT to be an approved strategy, but unfortunately the idea was shot down because HBOT wasn’t a ventilator. Truly unfortunate, and he believes that a lot of people passed away unnecessarily; and this study further proofs it.
Fig 1
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
